| (CNY) | Dec 2024 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | -138.85M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, 300199.SZ returned -21.7% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +23.9% |
| 1 year | -21.7% |
| 5 years | +313.6% |
| 10 years | +12.2% |
| All-time high | ¥34.89 (May 2015) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what ¥1,000 in 300199.SZ would be worth today ›No. Hybio Pharmaceutical Co., Ltd. has not paid a dividend in the past 12 months.
Hybio Pharmaceutical Co., Ltd. is part of the Healthcare sector.
Hybio Pharmaceutical Co., Ltd. has a market cap of 19.58B CNY, based on the latest quote.
